
Co-occurring schizophrenia, stimulant use disorder ‘challenging’ to treat
In a Healio Video Perspective from the American Psychiatric Association Annual Meeting, Dr. Randall F. White discusses the high prevalence of substance use disorders among patients with schizophrenia. He highlights the challenge of treating co-occurring stimulant use disorder and schizophrenia, as stimulants like methamphetamine can worsen psychosis. White stresses the importance of prioritizing treatment of…